In breast cancers, YB‐1 translationally controls the epithelial‐to‐mesenchymal transition (EMT) by activating expression of transcription factors such as SNAIL, TWIST, and ZEB2 to drive breast cancer EMT and metastasis 21. This evidence concerns the gene ZEB2 and breast carcinoma.